The Cancer Letter

Inside information on cancer research and drug development

In Brief

Pedro Torres-Ayuso receives $50,000 to study gene as target in squamous cell head and neck cancers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Pedro Torres-Ayuso, an assistant professor in the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center, received a $50,000 grant through the SPORE Career Enhancement Program. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Proton therapy demonstrates advantages for head and neck cancer in phase III trial preliminary data

According to preliminary data from a multi-institution phase III trial led by researchers at MD Anderson Cancer Center, intensity modulated proton therapy achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy as part of chemoradiation treatment for patients with oropharyngeal cancer. 
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account